142 related articles for article (PubMed ID: 17557556)
21. Non-Small Cell Lung Cancer as a Second Primary Among Patients With Previous Malignancy: Who Is at Risk?
Wu GX; Nelson RA; Kim JY; Raz DJ
Clin Lung Cancer; 2017 Sep; 18(5):543-550.e3. PubMed ID: 28412093
[TBL] [Abstract][Full Text] [Related]
22. Higher than expected association of clinical prostate and bladder cancers.
Singh A; Kinoshita Y; Rovito PM; Landas S; Silberstein J; Nsouli I; Wang CY; Haas GP
J Urol; 2005 May; 173(5):1526-9. PubMed ID: 15821472
[TBL] [Abstract][Full Text] [Related]
23. Multiple malignant tumors.
Chirila DN; Turdeanu NA; Constantea NA; Coman I; Pop T; Popp RA; Balacescu O; Vesa SC; Ciuce C
Chirurgia (Bucur); 2013; 108(4):498-502. PubMed ID: 23958092
[TBL] [Abstract][Full Text] [Related]
24. Increasing age and treatment modality are predictors for subsequent diagnosis of bladder cancer following prostate cancer diagnosis.
Singh AK; Mashtare TL; McCloskey SA; Seixas-Mikelus SA; Kim HL; May KS
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1086-94. PubMed ID: 20350797
[TBL] [Abstract][Full Text] [Related]
25. Subsequent primary cancers following bladder cancer.
Salminen E; Pukkala E; Teppo L; Pyrhönen S
Eur J Cancer; 1994; 30A(3):303-7. PubMed ID: 8204349
[TBL] [Abstract][Full Text] [Related]
26. Risk of second malignant neoplasms among long-term survivors of testicular cancer.
Travis LB; Curtis RE; Storm H; Hall P; Holowaty E; Van Leeuwen FE; Kohler BA; Pukkala E; Lynch CF; Andersson M; Bergfeldt K; Clarke EA; Wiklund T; Stoter G; Gospodarowicz M; Sturgeon J; Fraumeni JF; Boice JD
J Natl Cancer Inst; 1997 Oct; 89(19):1429-39. PubMed ID: 9326912
[TBL] [Abstract][Full Text] [Related]
27. Incidence of multiple primary bladder and prostate cancer in a central region of Italy. Umbria, 1994-2004.
Cassetti T; Scheibel M; Stracci F; Minelli L; La Rosa F
Tumori; 2007; 93(3):242-3. PubMed ID: 17679457
[TBL] [Abstract][Full Text] [Related]
28. Metachronous malignancies in men with previous prostate cancer in Umbria, Italy, 1994-2003.
Cassetti T; Stracci F; Minelli L; Scheibel M; Sapia IE; La Rosa F
Tumori; 2008; 94(1):7-10. PubMed ID: 18468327
[TBL] [Abstract][Full Text] [Related]
29. Second cancers among 40,576 testicular cancer patients: focus on long-term survivors.
Travis LB; Fosså SD; Schonfeld SJ; McMaster ML; Lynch CF; Storm H; Hall P; Holowaty E; Andersen A; Pukkala E; Andersson M; Kaijser M; Gospodarowicz M; Joensuu T; Cohen RJ; Boice JD; Dores GM; Gilbert ES
J Natl Cancer Inst; 2005 Sep; 97(18):1354-65. PubMed ID: 16174857
[TBL] [Abstract][Full Text] [Related]
30. Risk of subsequent primary cancers after carbon ion radiotherapy, photon radiotherapy, or surgery for localised prostate cancer: a propensity score-weighted, retrospective, cohort study.
Mohamad O; Tabuchi T; Nitta Y; Nomoto A; Sato A; Kasuya G; Makishima H; Choy H; Yamada S; Morishima T; Tsuji H; Miyashiro I; Kamada T
Lancet Oncol; 2019 May; 20(5):674-685. PubMed ID: 30885458
[TBL] [Abstract][Full Text] [Related]
31. Association of metabolic syndrome and its components with the risk of urologic cancers: a prospective cohort study.
Jiang R; Wang X; Li Z; Cai H; Sun Z; Wu S; Chen S; Hu H
BMC Urol; 2023 Sep; 23(1):150. PubMed ID: 37736725
[TBL] [Abstract][Full Text] [Related]
32. Association of spironolactone use with risk of urinary tract cancer in the general population: A matched population-based cohort study.
Chen LC; Yang HJ; Yu BH; Lee MS; Lin HY; Chiou WY; Liu DW; Hsu FC; Chew CH; Hung SK
PLoS One; 2024; 19(3):e0300391. PubMed ID: 38536840
[TBL] [Abstract][Full Text] [Related]
33. Radiation therapy for prostate cancer increases subsequent risk of bladder and rectal cancer: a population based cohort study.
Nieder AM; Porter MP; Soloway MS
J Urol; 2008 Nov; 180(5):2005-9; discussion 2009-10. PubMed ID: 18801517
[TBL] [Abstract][Full Text] [Related]
34. Comparative study on the prevalence of clinically detectable prostate cancer in patients with and without bladder cancer.
Kurokawa K; Ito K; Yamamoto T; Takechi H; Miyamoto S; Suzuki K; Yamanaka H
Urology; 2004 Feb; 63(2):268-72. PubMed ID: 14972469
[TBL] [Abstract][Full Text] [Related]
35. Risk of second primary tumors in men diagnosed with prostate cancer: a population-based cohort study.
Davis EJ; Beebe-Dimmer JL; Yee CL; Cooney KA
Cancer; 2014 Sep; 120(17):2735-41. PubMed ID: 24842808
[TBL] [Abstract][Full Text] [Related]
36. Bladder cancer and the risk of smoking-related cancers during followup.
Salminen E; Pukkala E; Teppo L
J Urol; 1994 Nov; 152(5 Pt 1):1420-3. PubMed ID: 7933174
[TBL] [Abstract][Full Text] [Related]
37. Family history of urogenital cancers in patients with bladder, renal cell and prostate cancers.
Randi G; Pelucchi C; Negri E; Talamini R; Galeone C; Franceschi S; La Vecchia C
Int J Cancer; 2007 Dec; 121(12):2748-52. PubMed ID: 17724720
[TBL] [Abstract][Full Text] [Related]
38. An Updated Meta-analysis on the Risk of Urologic Cancer in Patients with Systemic Lupus Erythematosus.
Yeo J; Seo MS; Hwang IC; Shim JY
Arch Iran Med; 2020 Sep; 23(9):614-620. PubMed ID: 32979908
[TBL] [Abstract][Full Text] [Related]
39. Bladder and kidney cancer following cyclophosphamide therapy for non-Hodgkin's lymphoma.
Travis LB; Curtis RE; Glimelius B; Holowaty EJ; Van Leeuwen FE; Lynch CF; Hagenbeek A; Stovall M; Banks PM; Adami J
J Natl Cancer Inst; 1995 Apr; 87(7):524-30. PubMed ID: 7707439
[TBL] [Abstract][Full Text] [Related]
40. Risk of subsequent primary cancer among prostate cancer patients in Bavaria, Germany.
Braisch U; Meyer M; Radespiel-Tröger M
Eur J Cancer Prev; 2012 Nov; 21(6):552-9. PubMed ID: 22433633
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
